Literature DB >> 16234434

Tissue plasminogen activator therapy for the eye.

R C Tripathi, B J Tripathi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16234434      PMCID： PMC1772940          DOI： 10.1136/bjo.2005.074401

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  37 in total

Review 1.  Mechanism of action of plasminogen activators.

Authors:  J I Weitz; R J Stewart; J C Fredenburgh
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

Review 2.  Pediatric cataracts.

Authors:  N Fallaha; S R Lambert
Journal:  Ophthalmol Clin North Am       Date:  2001-09

Review 3.  Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review.

Authors:  San-Ni Chen; Te-Cheng Yang; Cheng-Lien Ho; Ya-Hui Kuo; Yeung Yip; An-Ning Chao
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

4.  Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.

Authors:  Nick Georgiadis; Kostas Boboridis; Nick Halvatzis; Nicolas Ziakas; Vagia Moschou
Journal:  J Cataract Refract Surg       Date:  2003-04       Impact factor: 3.351

5.  Use of tissue plasminogen activator to revive blebs following intraocular surgery.

Authors:  M F Smith; J W Doyle
Journal:  Arch Ophthalmol       Date:  2001-06

6.  Filtering bleb thrombolysis with tissue plasminogen activator.

Authors:  J R Ortiz; S D Walker; P E McManus; L A Martinez; R H Brown; G J Jaffe
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

7.  Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.

Authors:  G J Jaffe; H Lewis; D P Han; G A Williams; G W Abrams
Journal:  Am J Ophthalmol       Date:  1989-08-15       Impact factor: 5.258

8.  Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.

Authors:  C M Klais; L O Hattenbach; G W Steinkamp; A A Zubcov; T Kohnen
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

9.  Recombinant tissue plasminogen activator following paediatric cataract surgery.

Authors:  J S Mehta; G G Adams
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

10.  Treatment of intracameral fibrinous membranes with tissue plasminogen activator.

Authors:  Nazmiye Erol; Ahmet Ozer; Seyhan Topbas; Nilgün Yildirim; Sumru Yurdakul
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 Nov-Dec
View more
  3 in total

1.  Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.

Authors:  Hetian Lei; Gisela Velez; Peter Hovland; Tatsuo Hirose; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

2.  Tissue Plasminogen Activator Effects on Fibrin Volume and the Ocular Proteome in a Juvenile Rabbit Model of Lensectomy.

Authors:  Jonathon B Young; Amanda Rae Buchberger; Joseph D Bogaard; Linda Berg Luecke; Matthew Runquist; Christine M B Skumatz; Iris S Kassem
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

Review 3.  The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review.

Authors:  Ainul Basirah Ibramsah; Aliff Irwan Cheong; Wan Norliza Wan Muda; Mohtar Ibrahim
Journal:  Rom J Ophthalmol       Date:  2022 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.